Excerpt from BioWorld Today

In terms of their specificity, biologics are magic bullets – or perhaps, magic magnets: Unlike bullets, they do not penetrate their target.

"There hasn't previously been an opportunity to address intracellular pathways with biological molecules," Alex Franzusoff told BioWorld Today. Franzusoff is CEO of Cambridge, Mass. based start-up Permeon Biologics, a company that hopes to change all that.

Click below to view the full BioWorld Today story:

http://www.permeonbio.com/company_news.php